DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | |
DEMOGRAPHIC DETAILS OF DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Race |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
White |
1,886 |
73.73 |
Black |
462 |
18.06 |
Hispanic |
104 |
4.07 |
|
|
|
|
|
|
|
|
|
|
|
|
Age Group ( Years ) |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
Less than 65 |
804 |
31.43 |
65 to 69 |
432 |
16.89 |
75 to 79 |
362 |
14.15 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ICD PROCEDURE CODES FOR DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | |
Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
Urology |
Testes Procedures |
Testes Procedures |
4019 |
Unspecified essential hypertension |
NA |
666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
2724 |
Other and unspecified hyperlipidemia |
NA |
446 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
I10 |
Essential (primary) hypertension |
680 |
441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
25000 |
Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled |
NA |
379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
5990 |
Urinary tract infection, site not specified |
NA |
364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
E785 |
Hyperlipidemia, unspecified |
348 |
339 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
6084 |
Other inflammatory disorders of male genital organs |
NA |
313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
6040 |
Orchitis, epididymitis, and epididymo-orchitis, with abscess |
NA |
313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
5849 |
Acute kidney failure, unspecified |
NA |
295 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Testes Procedures |
Testes Procedures |
185 |
Malignant neoplasm of prostate |
NA |
290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|